XClose

UCL Institute for Precision Medicine

Home
Menu

UCL Institute for Precision Medicine

UCL Institute of Precision Medicine homepage image


Background

Precision Medicine is the next generation of healthcare research that has the potential to provide significant benefits to patients, and affect strategic shifts in the way healthcare is delivered. It uses an individual's genetic profile to guide decisions about the prevention, diagnosis, and treatment of disease. Developing new diagnostic tests and expanding the use of biomarkers enables the identification of the molecular cause of disease, and ultimately supports the development of novel, more precisely targeted treatments. 


Case studies

Case study 1

Nina’s story

Nina’s story

Case study 2

Genomics get personal: Personal Genome Project UK

Personal Genome Project UK

Case study 3

The Exenatide trial in Parkinson's disease

The Exenatide trial in Parkinson's

Genomic profiling

Genomic profiling

Precision medicine uses an individual's genetic profile to guide decisions made in regard to the prevention, diagnosis, and treatment of a disease. Developing new diagnostic tests and biomarkers that allow the identification of the molecular cause of a disease, will ultimately support the development of novel more precisely targeted treatments.

Diagnostics

Diagnostics

The goal of the UCL Institute for Precision Medicine is to accelerate the development of new diagnostics, such as in vivo and in vitro tests, biomarkers an imaging technologies

Clinical trials

Clinical trials

Clinical trials are the means by which investigational agents, devices, or biologics, such as chemotherapy agents, blood products, or gene therapies are scientifically evaluated in human volunteers for safety and efficacy. 

Moving forward, innovative clinical trial designs will be necessary to progress toward a more personalised approach. 

Target discoveries and markers

Target discoveries and biomarkers

Target discovery involves the identification and early validation of disease-modifying targets. Biomarkers play an important role in this process as they can be used to indicate disease progression and can be measured accurately with reproducible results.

Individualised medicine clinics

Precision medicine clinics

Plans in development.

Precision therapies

Precision therapies

The UCL Institute for Precision Medicine aims to accelerate the development of novel drugs and targeted therapies (antisense oligonucleotide, cell and gene therapies). 

Contact Us

Ruth Jamieson

Strategic Coordinator, UCL Personalised Medicine Domain

Email: r.jamieson@ucl.ac.uk
Phone: 
+44 (0)20 7679 8111